Peter Wong

Title: Innovations of Peter Wong in Kinase Inhibition

Introduction

Peter Wong is an accomplished inventor based in Brisbane, California. He has made significant contributions to the field of pharmaceutical sciences, particularly in the development of kinase inhibitors. His work focuses on creating novel crystalline forms that enhance the efficacy of these compounds.

Latest Patents

Peter Wong holds a patent for "Crystalline forms and salt forms of a kinase inhibitor." This invention relates to crystalline forms of the free base of the c-Met inhibitor, Compound 1. It also encompasses crystalline forms of salts of Compound 1. Furthermore, the invention includes pharmaceutical compositions comprising the solid polymorphs of the free base and salts of Compound 1. The methods described in the patent aim to treat diseases, disorders, or syndromes that are mediated by modulating the in vivo activity of a protein kinase. He has 1 patent to his name.

Career Highlights

Peter Wong is currently employed at Exelixis, Inc., a company known for its focus on innovative cancer therapies. His role involves extensive research and development in the field of kinase inhibitors, contributing to the advancement of targeted therapies.

Collaborations

Throughout his career, Peter has collaborated with notable colleagues, including Stephan D Parent and Sagar Shakya. These collaborations have fostered a productive environment for innovation and research.

Conclusion

Peter Wong's contributions to the field of kinase inhibition exemplify the impact of innovative research in pharmaceuticals. His work continues to pave the way for advancements in treatment methodologies.